1)Guyer DR, Yannuzzi LA, Slakter JS et al:Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112:1057-1062, 1994
2)Piccolino FC, Borgia L:Central serous chorioretinopathy and indocyanine green angiography. Retina 14:231-242, 1994
3)Daruich A, Matet A, Dirani A et al:Central serous chorioretinopathy:Recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82-118, 2015
4)Izumi T, Koizumi H, Maruko I et al:Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy. Br J Ophthalmol 101:433-437, 2017
5)Maruko I, Koizumi H, Hasegawa T et al:Subthreshold 577nm micropulse laser treatment for central serous chorioretinopathy. PLoS One 12:e0184112, 2017
6)Iida T, Yannuzzi LA, Spaide RF et al:Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina 23:1-7, 2003
7)Izumi T, Koizumi H, Takahashi Y et al:Differences in choroidal structures between idiopathic and steroid-induced central serous chorioretinopathy. J Vitreoretin Dis 3:10-15, 2018
8)Chan WM, Lai TY, Lai RY et al:Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy:one-year results of a prospective study. Retina 28:85-98, 2008
9)Maruko I, Iida T, Sugano Y et al:Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117:1792-1799, 2010
10)Fung AT, Yannuzzi LA, Freund KB:Type 1(sub-retinal pigment epithelial)neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina 32:1829-1837, 2012
11)Maruko I, Iida T, Sugano Y et al:Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina 31:1603-1608, 2011